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OBJECTIVES The purpose of this study was to identify trends and factors associated with outcomes of
persistent truncus arteriosus (PTA).
BACKGROUND Although there have been significant improvements, PTA continues to be associated with
significant morbidity and mortality.
METHODS We undertook a review of all consecutive cases of PTA (n 5 205) presenting at our institution
from 1953 to 1997. Data were collected regarding demographics, anatomy, management
(surgical palliation and repair) and outcomes (mortality and reoperation).
RESULTS Significant trends (p # 0.001) related to groups defined by year of birth were as follows:
number of cases (1953–1967, n 5 13; 1968–1977, n 5 42; 1978–1987, n 5 69; 1988–1997,
n 5 81), median age at first assessment (8 months, 42 days, 7 days and 2 days, respectively),
proportion who did not have any surgery (58%, 27%, 22% and 11%), proportion who had an
initial palliative procedure (25%, 37%, 6% and 2%), proportion who underwent PTA repair
(31%, 59%, 72% and 88%), median age at PTA repair (11.2 years, 1.1 years, 1.6 months and
12 days) and proportion dying before hospital discharge after repair (50%, 63%, 56% and
41%). Since 1995, mortality before hospital discharge after repair has further decreased to
2/11 (18%). Increasing time to initial conduit replacement in hospital survivors was
significantly related to larger sized conduit at repair (p 5 0.02) and use of pulmonary
homografts (vs. aortic homografts or xenografts; p 5 0.002). Interventional catheterization to
address conduit obstructions significantly increased conduit longevity.
CONCLUSIONS Significant improvements in PTA outcomes are evident with trends toward earlier age at
assessment and complete repair. (J Am Coll Cardiol 1999;34:545–53) © 1999 by the
American College of Cardiology
Persistent truncus arteriosus (PTA) is an uncommon con-
genital cardiac malformation accounting for approximately
1.2% of all congenital heart malformations (1). Features of
PTA include a single great artery arising from the base of
the heart, that supplies systemic, coronary and pulmonary
blood flow, together with a ventricular septal defect. Both
characteristics are believed to result from failure of proper
conotruncal septation. The two main classification systems
used to describe the anatomy of PTA are those of Collett &
Edwards (1949) and Van Praagh (1965) (2). The natural
history of children born with PTA is such that up to 80% or
more die within the first year of life without surgical
intervention (1,3,4,5). The first successful surgical repair of
PTA was performed by McGoon, Rastelli and Ongley (6)
in 1967. They used an aortic homograft including the aortic
valve to establish continuity from the right ventricle (RV) to
the pulmonary artery (PA). Since then, various means of
reconstruction have been developed, and controversies re-
main concerning which method is the best to use and at
what age surgery should optimally be performed. The main
long-term management issues relate to conduit stenosis and
truncal valve incompetence and stenosis. The necessary
reoperations to address these complications are associated
with further risk of mortality and morbidity. Risk factors
and outcomes related to this lesion have been incompletely
defined. We therefore sought to determine the changing
patterns of mortality and morbidity related to PTA at a
single institution and to define potential factors associated
with outcomes related to management.
METHODS
Study population. All patients with a diagnosis of PTA
were identified in the Cardiology Database of the Division
of Cardiology, The Hospital for Sick Children, and were
included in the present study. The diagnosis was verified in
the medical record for all patients, and patients who were
miscoded and did not have PTA were excluded.
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Measurements. The cardiology and hospital records for all
patients were reviewed. Data collected included demo-
graphics, anatomic diagnoses, status at presentation, surger-
ies, interventional catheterization procedures and follow-up
status.
Data analysis. Data are described as frequencies, medians
with ranges and means with standard deviations. Where
there is missing data, the available values are given. Changes
in characteristics, management and outcomes over time
were sought by creating four groups based on birth date:
1953–1967, 1968–1977, 1978–1987 and 1988–1997. Dif-
ferences between these groups were sought using Mantel
Haentzel chi-square tests, Kruskal-Wallis analysis of vari-
ance and analysis of variance. Associations between the
number of PTA valve cusps and presence, and severity of
stenosis and regurgitation were sought with Mantel-
Haentzel chi-square tests. Severity of stenosis was related to
severity of regurgitation with gamma coefficient. Factors
associated with hospital mortality after PTA repair were
sought with Fisher exact tests, chi-square tests, Kruskal-
Wallis analysis of variance and Student t tests. Kaplan-
Meier estimates of freedom from initial RV to PA conduit
replacement were plotted, and factors associated with de-
creased time to initial conduit replacement were tested with
log rank and Wilcoxon tests. A p , 0.05 was set as the level
of statistical significance.
RESULTS
Patient Characteristics
Demographics. From the Cardiology Database, 205 pa-
tients were identified and verified with the diagnosis of
PTA, and date of birth ranged from January 1, 1953 to
December 31, 1997. Cases were grouped into birth cohorts
as follows: 1953–1967, n 5 13; 1968–1977, n 5 42;
1978–1987, n 5 69 and 1988–1997, n 5 81. There were 76
males and 129 females.
Presentation. The median age at presentation (n 5 202)
was 4 days with a range from birth to 5.8 years. Median age
of participants at presentation became progressively younger
with subsequent birth cohorts (p , 0.001) as follows:
1953–1967, 92 days (n 5 13); 1968–1977, 17 days (n 5
41); 1978–1987, 2 days (n 5 68) and 1988–1997, 1 day
(n 5 80). Clinical signs at presentation (n 5 201) were
congestive heart failure in 117 patients (58%), cyanosis in 89
(44%), respiratory infection or distress in 33 (16%), failure
to thrive in 7 (3%), cardiac arrhythmias in 3 (1%) and
clubbing of fingers and toes in two patients (1%). One
patient presented in a moribund state. The methods used to
establish the diagnosis (n 5 200) consisted of echocardiog-
raphy alone in 103 patients (51%), cardiac catheterization
alone in 63 (31%), both echocardiography and catheteriza-
tion in 29 (15%), echocardiography with magnetic reso-
nance imaging in 2 (1%) and at postmortem examination in
3 patients (2%).
The median age at diagnosis (n 5 202) was 7 days with
a range from 22 days before birth at fetal echocardiography
to 15 years. Median age at diagnosis became progressively
younger with subsequent birth cohorts (p , 0.001) as
follows: 1953–1967, 8 months (n 5 13); 1968–1977, 42
days (n 5 41); 1978–1987, 7 days (n 5 68) and 1988–1997,
2 days (n 5 80).
Cardiac anatomy. The specific PTA anatomy of the pa-
tients (n 5 202) was as follows: single pulmonary trunk and
ascending aorta arising from the PTA in 140 patients
(69%), right and left PAs arising from separate orifices close
together from the dorsal wall of the PTA in 41 (20%), one
or both PAs arising from the separate orifices at the lateral
aspects of the PTA in 14 (7%), the branch PAs immediately
adjacent to one another with a common orifice but no
common trunk following attachment from the PTA in 4
(2%), no true branch PAs arising from the PTA (Collett
and Edwards Type 4) in 2 (1%) and in one patient, the right
PA arose from the posterior wall of the PTA with the left
PA arising from a main PA from the PTA (,1%). Other
associated cardiovascular anomalies are described in Table 1.
The reported prevalence of interatrial communications re-
flects only those defects noted at echocardiography, cardiac
catheterization, surgery or autopsy and may be an underes-
timation of defects that may not have been adequately
imaged or that closed spontaneously.
The number of PTA valve leaflets (n 5 156) were two in
11 patients (7%), three in 85 (54%), four in 58 (37%), five
in 1 (1%) and six in 1 patient (1%). Persistent truncus
arteriosus valve regurgitation was described in 123 (69%) of
178 patients and was graded subjectively at the time of
either echocardiography or cardiac catheterization in 115
patients as mild in 88 (77%), moderate in 22 (19%) and
severe in 5 patients (4%). Persistent truncus arteriosus valve
stenosis was described in 75 (56%) of 135 patients and was
graded subjectively in 72 patients as mild in 49 (68%),
moderate in 11 (15%) and severe in 12 patients (17%).
Persistent truncus arteriosus valve abnormalities signifi-
cantly impacted on the incidence of both valve stenosis and
regurgitation. Moderate to severe valve stenosis was more
likely in patients with two valve cusps (2 of 9; 22%) or four
or more valve cusps (14 of 44; 32%) than it was in those with
three valve cusps (5 of 65; 8%; p 5 0.005). Moderate to
severe valve regurgitation was more likely in patients with
four or more valve cusps (17 of 57; 30%) than it was in those
with two valve cusps (0 of 9; 0%) or three valve cusps (8 of
73; 11%; p 5 0.007). The degree of valve stenosis was
Abbreviations and Acronyms
PA 5 pulmonary artery
PTA 5 persistent truncus arteriosus
RV 5 right ventricle
546 Williams et al. JACC Vol. 34, No. 2, 1999
Outcomes of Persistent Truncus Arteriosus August 1999:545–53
significantly correlated with the degree of valve regurgita-
tion (gamma 0.526; error 0.099).
Noncardiac abnormalities. Noncardiac abnormalities
were described in 81 patients and included DiGeorge
syndrome (n 5 22), dysmorphic features (n 5 18), neonatal
seizures (n 5 10), cleft palate (n 5 6), renal abnormalities
(n 5 6), bilateral choanal atresia (n 5 3), cardiofacial
syndrome (n 5 3), esophageal atresia (n 5 2), tracheo-
esophageal fistula (n 5 1), Hemophilia A (n 5 1), chest
wall anomalies (n 5 1), omphalocele (n 5 1), quadriplegia
(n 5 1), absent corpus callosum (n 5 1), Noonan syndrome
(n 5 1) and Potter syndrome (n 5 1).
Management and Outcomes
The management and survivorship for the patients is shown
in Figure 1. The management and status of three patients is
unknown.
Presurgical outcomes. No surgery was performed in 42
(21%) patients; 31 (74%) of these patients subsequently died
at a median age of 11 days (range: birth to 19.4 years), with
27 patients dying before 6 months of age. The median
interval from diagnosis to death in these patients was 3 days
(range: ,1 day to 18.9 years), with one patient having been
diagnosed at autopsy. With subsequent birth cohorts the
proportion of patients who did not have any surgery
decreased significantly as follows: 1953–1967, 7/12 (58%);
1968–1977, 11/41 (27%); 1978–1987, 15/69 (22%) and
1988–1997, 9/80 (11%; p 5 0.001). Cause of death in most
was due to metabolic acidosis with myocardial dysfunction,
arrhythmia and cardiac arrest, with organ failure in other
systems. Patients who died before any surgery were signif-
icantly more likely to have moderate to severe PTA valve
stenosis at diagnosis (11/21; 52%) than the remaining
patients (12/114, 11%; p 5 0.001), but there was no
significant difference in the incidence of moderate to severe
valve regurgitation (7/28, 25%; vs. 20/150, 13%, respec-
tively; p 5 0.12). In addition, there were 11 patients who
had no surgery who were last known to be alive at a median
age of 5.0 years (range, 2 days to 18.1 years), and at a
median interval from diagnosis of 4.7 years (range, 2 days to
17.8 years).
Palliative surgical procedures. Palliative surgical proce-
dures were performed initially in 23/199 (12%) patients, at
a median age of 2.5 months (range, 2 days to 2.5 years) and
at a median interval from diagnosis of 18 days (range, ,1
day to 1.3 years). Palliative procedures included pulmonary
artery banding in 21 patients (in conjunction with repair of
interrupted aortic arch in 2 patients) and placement of a
systemic to pulmonary arterial shunt in 2 patients (in
conjunction with repair of interrupted aortic arch in 1
patient). The proportion of patients whose initial surgery
was a palliative procedure decreased significantly with sub-
sequent birth cohorts as follows: 1953–1967, 3/12 (25%);
1968–1977, 14/38 (37%); 1978–1987, 4/68 (6%) and
1988–1997, 2/81 (2%); p 5 0.001. In addition, there were
significant trends with subsequent birth cohorts towards a
younger age at surgery and a shorter interval since diagnosis
in those patients who underwent palliative procedures.
There were eight deaths (35%) in these patients, at a median
interval of 1.5 days after surgery (range, ,1 day to 12 days).
Patients who died versus those who survived after palliative
surgery were significantly younger at surgery (median age
11.5 days vs. 5.0 months, respectively; p , 0.05) with a
trend toward a shorter interval from diagnosis to surgery
(median interval 5 days vs. 22 days; p 5 0.09). Of the 15
patients who survived palliative surgery, 11 went on to have
repair of PTA (with eight hospital deaths and one late death
at conduit replacement), and 4 patients were late deaths
after hospital discharge occurring at 29 days, 1.7 months,
1.4 years and 13.3 years after surgery.
Persistent truncus arteriosus repair. A total of 148 of 202
(73%) patients underwent repair of PTA. The proportion of
patients who underwent PTA repair increased significantly
(p 5 0.001) with subsequent birth cohorts as follows:
1953–1967, 4/13 (31%); 1968–1977, 24/41 (59%); 1978–
1987, 50/69 (72%) and 1988–1997, 70/80 (88%). Before
repair 53/138 (38%) patients were managed in the intensive
care unit with 41/138 (30%) patients having been mechan-
ically ventilated for a median of 2 days (range, 1 day to 92
days). Reasons for preoperative ventilation included elective
in 15 patients, respiratory compromise in 19, hemodynamic
Table 1. Associated Cardiovascular Anomalies (N 5 202)
Anomaly
Patients
No. %
Atrial septal defect/PFO 125 62
Right aortic arch 60 30
Patent ductus arteriosus 37 18
Stenotic or hypoplastic pulmonary arteries 32 16
Interrupted aortic arch 28 14
Aberrant right or left subclavian artery 12 6
Persistent left superior vena cava 12 6
Coronary artery anomaly 11 5.4
Coarctation of the aorta 3 1.5
Anomalous pulmonary venous drainage 3 1.5
Hypoplasia of the left lung 3 1.5
Anomalous origin of subclavian arteries 2 1
Single ventricle 1 0.5
Absent R-AV connection 1 0.5
Hypoplastic RV 1 0.5
Aneurysm of septum primum 1 0.5
AVSD 1 0.5
Tubular hypoplasia of aortic arch 1 0.5
PTA committed to LV only 1 0.5
Upstairs/downstairs ventricular relationship 1 0.5
Stenosis proximal LSCA 1 0.5
Azygous continuation of IVC 1 0.5
AVSD 5 atrioventricular septal defect; IVC 5 inferior vena cava; LSCA 5 left
subclavian artery; LV 5 left ventricle; PFO 5 patent foramen ovale; PTA 5
persistent truncus arteriosus; R-AV 5 right atrioventricular; RV 5 right ventricle.
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instability in 4 and unknown reasons in 3 patients. On
electrocardiograms obtained just before surgery (n 5 134),
there was no evidence of myocardial ischemia in 66 patients
(49%), ST segment changes only in 30 (23%), T wave
flattening or inversion only in 22 (16%), both T wave and
ST segment changes in 14 (10%) and T wave changes with
a strain pattern in 2 patients (2%).
Median age at repair (n 5 147) was 38 days (range, 2 days
to 21.1 years) and decreased significantly (p , 0.001) with
subsequent birth cohorts as follows: 1953–1967, 11.2 years;
1968–1977, 1.1 years; 1978–1987, 1.6 months and 1988–
1997, 12 days. Mean cardiopulmonary bypass time (avail-
able for 143 patients) was 133 6 58 min with a mean aortic
cross-clamping time (available for 131 patients) of 52 6
25 min. Circulatory arrest was used in 90 of 132 (68%)
patients for which this could be ascertained, with a mean
duration (available for 81 of the 90 patients) of 38 6
20 min. The RV to PA conduit was valved in 144/144
patients, and the type of conduit (n 5 144) was a xenograft
in 43% (Hancock in 61%, Polystan in 36% and Goretex in
3%), cryopreserved aortic homograft in 37%, cryopreserved
pulmonary homograft in 19% and an autograft (direct tissue
connection) in 1%. In addition to repair of interrupted
aortic arch where applicable at the time of PTA repair, six
patients had replacement of the PTA valve with two
additional patients having repair of the PTA valve.
Hospital mortality. There were 74 deaths (50%) before
hospital discharge, with 43 deaths either in the operating
room or within the first 24 h after surgery (range up to 14
days). Cumulative deaths versus consecutive repairs is
shown in Figure 2. Causes of death included pulmonary
hemorrhage in one patient, intracranial hemorrhage in one
and cardiac tamponade in one patient, with the remainder
of patients dying from circulatory failure. Hospital mortality
improved significantly (p , 0.001) with subsequent birth
cohorts as follows: 1953–1967, 2/4 (50%); 1968–1977,
15/24 (63%); 1978–1987, 28/50 (56%) and 1988–1997,
29/70 (41%). Since 1995, an aggressive preoperative inten-
sive care management program has been started and com-
bined with one cardiac surgeon designated to repair these
patients, with an apparent improvement in hospital mortal-
ity during 1996–1997 to 2 of 11 (18%).
Factors associated with hospital mortality with PTA
repair were sought (Table 2). Hospital mortality was not
significantly related to preoperative PTA anatomy (PA
connections), PTA valve stenosis or regurgitation, number
of PTA valve cusps, presence of a major associated cardiac
anomaly, previous palliative procedures, preoperative man-
agement in the intensive care unit or use of mechanical
ventilation, presence of ischemic changes on the preopera-
tive electrocardiogram, age at PTA repair or cardiopulmo-
nary bypass time. Increased hospital mortality was signifi-
cantly related to earlier date of surgical repair in the overall
experience.
Total early mortality. If deaths occurring before PTA
repair are combined with hospital mortality after repair,
then total early mortality was 113/202 (56%). Total early
mortality did not change significantly (p 5 0.20) with
subsequent birth cohorts as follows: 1953–1967, 5/12
(42%); 1968–1977, 28/41 (68%); 1978–1987, 42/69 (61%)
and 1988–1997, 38/80 (48%), with a mortality in the last 5
years of 24/41 (59%) and in the most recent 2 years of 4/11
(36%).
Late mortality. There were 11 late deaths (15%) in the 74
hospital survivors after PTA repair, which occurred at a
median interval after repair (n 5 10) of 5.5 months (range,
1.8 months to 5.3 years). Cause of late death was related to
Figure 1. Management and outcomes. PTA 5 persistent truncus arteriosus.
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pulmonary infection in three patients, pulmonary hyperten-
sion in one, cardiac failure in one, arrhythmia in one,
thrombosis of the conduit valve in one, hospital death after
conduit replacement in one and was unknown in three
patients. Kaplan Meier survival estimates after hospital
discharge in survivors after repair are shown in Figure 3,
with survival of 83% up to 20.3 years. Survival after hospital
discharge was not significantly related to demographics,
PTA and PTA valve anatomy, previous palliative proce-
dures, age and date of PTA repair or cardiopulmonary
bypass time.
Subsequent procedures. Persistent truncus arteriosus valve
replacement was required in four patients, with a second
valve replacement required in one of these patients. Conduit
replacement was required during follow-up procedures in 34
of the 74 survivors (46%), with Kaplan-Meier estimates of
freedom from initial conduit replacement shown in Figure
4. A second conduit replacement was performed in seven
patients with one patient requiring a third replacement.
Freedom from initial conduit replacement was not signifi-
cantly related to patient age or date of PTA repair but was
significantly increased with increasing size of initial conduit
placed (log rank test p 5 0.02; Wilcoxon test p 5 0.01).
This was also significantly related to the type of initial
homograft material (log rank test p 5 0.002, Wilcoxon test
p 5 0.008), with pulmonary homografts lasting the longest,
aortic homografts next followed by xenografts (Fig. 5).
Interventional cardiac catheterization was performed in 31
patients (42%), initially for branch PA stenoses in 19
patients, for conduit or conduit valve stenosis in 9 and for
both in 4 patients, with 1 patient having balloon dilation of
aortic arch obstruction. Subsequent additional interven-
tional catheterization procedures were performed in 13 of
these patients. The use of interventional cardiac catheter-
ization to address conduit and conduit valve stenosis (n 5
13 patients) before first conduit replacement or last known
follow-up procedure did not significantly relate to freedom
from conduit replacement (log rank test p 5 0.93; Wilcoxon
test p 5 0.96) versus those patients who did not have an
interventional procedure. However, if an assumption is
made that the date of the interventional procedure might be
the date of initial conduit replacement if interventional
catheterization had not been performed, then these patients
would have been significantly more likely to have earlier
initial conduit replacement (log rank test p , 0.001;
Wilcoxon test p , 0.001) (Fig. 6).
DISCUSSION
Natural history. The natural history of PTA in the pre-
surgical era has not been well-documented. In 1957, Ander-
son et al. (7) described a group of 14 patients with PTA,
with 11 of them diagnosed at autopsy and 3 confirmed at
surgery. The median age at diagnosis was 3 months. In
1976, Calder et al. (8) noted that the diagnosis in their study
group of 100 patients was still primarily made at autopsy
(79%) at a median age of 5 weeks. Most patients died in
early infancy (7–10). In our study, we found that 31 of 42
patients (74%) that had no surgery died at a median age of
11 days with a range from birth to 19.4 years, with 84%
(26/31) being younger than 6 months old. Hicken et al. (9)
first reported a case of a woman with PTA that died at the
age of 38 years. Three published long-term survival studies
of unrepaired patients report mortality rates of 61% with
death occurring at a median age of 1.5 years (10), 81% with
a median age of 5 weeks (8) and 100% with a median age of
4.5 months (7), respectively.
Palliative surgical procedures. The role of palliative sur-
gical procedures such as PA banding to manage PTA has
changed considerably during the years. Trends toward
decreased palliative procedures were accompanied by trends
toward younger age at PTA repair. In the past, PTA
patients underwent PA banding if medical treatment failed
to control congestive heart failure (5), often with a view to
PTA repair at an older age. Palliation with PA banding is
currently not believed to have any advantages (8,11) and is
associated with high mortality rates (4,5,12–16). Poirier et
al. (16) reported in a literature review regarding PA banding
in PTA patients that the pooled overall mortality rate was
59% (45/76) and ranged between individual series from 0%
(0/6) to 100% (3/3). Singh et al. (15) reported 11 deaths
(73%) after PA banding in 15 patients. These reports of
high mortality are similar to our experience, where 11/23
(48%) patients either died early or late after PA banding.
Furthermore, PA banding does not sufficiently prevent
pulmonary vascular obstructive disease, which has been
reported to occur in 10% to 15% of patients undergoing PA
banding (5); this complication renders these patients inop-
erable. Pulmonary artery banding is now reserved for pa-
tients that have increased pulmonary blood flow and are not
deemed suitable candidates for definitive repair of their
lesion. The decreasing use of initial palliative procedures in
our series from 25% in 1953–1967 to 2% in 1988–1997
reflects these changes in management policy.
Figure 2. Cumulative hospital mortality with consecutive surgical
repairs of persistent truncus arteriosus. PTA 5 persistent truncus
arteriosus.
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Table 2. Factors Associated with Death Before Hospital Discharge in Patients Undergoing
Repair of Persistent Truncus Arteriosus (N 5 148)
Variable Hospital Mortality % p*
PTA anatomy
PA connection
Single common
pulmonary trunk
50/96 52
Branch PA’s from
separate orifaces but
close together on PTA
16/35 46
Other 8/15 53 0.80
Number of PTA valve cusps
Two 4/7 57
Three 36/69 52
Four or more 24/44 50 0.95
Degree of PTA valve
stenosis
None 25/52 48
Mild 20/42 48
Moderate to severe 6/10 60 0.77
Degree of PTA valve
regurgitation
None 20/42 48
Mild 38/77 49
Moderate to severe 8/14 57 0.83
Associated major
cardiovascular anomaly
Absent 64/133 48
Present 10/13 67 0.28
Previous palliative surgical
procedure
Absent 64/133 48
Present 8/11 73 0.21
Preoperative management in
the intensive care unit
Absent 43/85 51
Present 28/53 53 0.80
Preoperative mechanical
ventilation
Absent 49/97 51
Present 22/41 54 0.74
Presence of preoperative
ischemic changes
on electrocardiogram
Absent 31/67 46
Present 38/67 57 0.23
Variable
Hospital Survivors
(n 5 74)
Deaths
(n 5 74) p
Median (range) date of surgery 04/1989 09/1986 0.02
(09/1979 to 09/1997) (04/1971 to 06/1997)
Median (range) age at repair 58 days 23 days 0.19
(n 5 73, 2 days to 21.1 yrs) (2 days to 9.6 yrs)
Mean (61 SD)
cardiopulmonary bypass time
(min) 131 6 57 136 6 61 0.63
(n 5 70) (n 5 73)
PA 5 pulmonary artery; PTA 5 persistent truncus arteriosus; SD 5 standard deviation; yrs 5 years.
*From chi-square tests to compare categorical variables, Kruskal-Wallis analysis of variance to compare medians and Student
t test to compare means.
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Age at repair. Age at PTA repair has been decreasing over
the years. Overall median age at repair in this study was 38
days, but decreased significantly with subsequent birth
cohorts from 11.2 years to 12 days. This trend is supported
in the published literature from the past 30 years, with
reported median ages ranging from 3.5 months to 7.3 years
(1,3,17–19). More recent studies published in the last 15
years report that age at repair has decreased dramatically,
with median ages ranging from 8 to 41 days (11,20–23). A
possible explanation for this trend is the improvements in
neonatal cardiothoracic surgery combined with a desire to
prevent pulmonary vascular obstructive disease in the pa-
tients who are at very high risk.
Hospital mortality after PTA repair. Early mortality rates
after PTA repair vary considerably in previous series. Sano
et al. (23) reported no early mortality in a series of seven
patients undergoing repair from 1985–1989. Other series
from a similar time period report early mortality rates of 9%
(1986–1988) (11), 11% (1986–1992) (21), 17.5% (1986–
1991) (22) and 15.6% (1982–1990) (4), although in the
latter study, the mortality rate decreased to 8.3% during the
last 4 years. Series before 1982 have shown higher mortali-
ty rates, varying from 11% (12) to 42% (13), with most
series having early mortality rates of more than 25%
(13,14,18,19,24). This trend toward decreasing mortality
with time was observed in our large series. Hospital mor-
tality improved significantly with subsequent birth cohorts,
although it still remained high—41% for the last birth
cohort (1988–1997). During 1996–1997, however, hospital
mortality further declined to 18%, which is comparable with
contemporary reports.
Factors associated with mortality after PTA repair. We
noted only one significant factor associated with increased
mortality before hospital discharge after PTA repair—
earlier date of surgical repair in the overall experience. Age
at repair was not significantly related to hospital mortality.
Although these findings are comparable with those of some
studies (3,17,21), Lacour-Gayet et al. (20) have reported
that age younger than one month remains an incremental
risk factor. Others have reported that increasing age was a
risk factor for hospital mortality (18,22). Previous palliative
surgeries performed on patients that subsequently went on
to have PTA repair did not significantly increase hospital
mortality. However, it must be mentioned that in our
experience, 8 (73%) of the 11 patients that had repair after
a palliative procedure did not survive to hospital discharge.
The presence of interruption of the aortic arch has been
previously reported to be a risk factor for mortality. Pearl et
al. (4) reported that the presence of interruption of the
aortic arch increased early mortality with PTA repair. Bove
et al. (21) reported that associated cardiac defects were not
significantly associated with increased mortality. We like-
wise did not identify an association between other cardiac
defects and hospital mortality. This is in contrast with the
series reported by Hanley et al. (22) in which interruption of
the aortic arch was a significant risk factor for mortality after
PTA repair.
Conduit reoperations. Thirty-four patients underwent 42
conduit replacements. There was one hospital death after
replacement. Smaller conduit size was a significant factor
associated with a shorter time to initial conduit reoperation.
Use of a pulmonary homograft versus an aortic homograft or
a xenograft was associated with greater initial conduit
longevity. Heinemann et al. (25) noted similar results. They
noted that the use of aortic homografts are a significant risk
factor for early replacement and encouraged the use of a
pulmonary homograft. There are many advantages in using
a pulmonary homograft (26). However, Morshuis et al. (27)
reported the use of a pulmonary homograft in the recon-
struction of PTA in an infant, with severe conduit valve
Figure 3. Kaplan-Meier estimates of late death after hospital
discharge in survivors of repair of persistent truncus arteriosus.
Vertical lines represent 95% confidence limits. PTA 5 persistent
truncus arteriosus.
Figure 4. Kaplan-Meier estimates of freedom from first right
ventricle to pulmonary artery conduit replacement after repair of
persistent truncus arteriosus. Data relates to hospital survivors after
repair of persistent truncus arteriosus; vertical lines represent 95%
confidence limits. PA 5 pulmonary artery; PTA 5 persistent
truncus arteriosus; RV 5 right ventricle.
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stenosis one year later. They felt that prevention of pulmo-
nary regurgitation was the only advantage to the valved
conduit. Interventional cardiac catheterization (balloon di-
lation with or without endovascular stenting) to address
conduit and conduit valve stenosis was performed in 31
patients before the first conduit reoperation. This did not
appear to have a significant influence on freedom from
conduit replacement, unless the assumption was made that
conduit reoperation would have occurred at the time of
catheter intervention if it had not been performed. This
compares favorably with published studies of balloon dila-
tions and stent implantations in RV to PA conduits. Lloyd
et al. (28) reported successful dilation of stenotic conduit
valve in three of six patients, with important increases in
conduit longevity. Ensing et al. (29) reported relief of
conduit obstruction in 8 of 11 patients undergoing balloon
dilation. One patient returned for conduit replacement 1.5
years after the procedure. Powell et al. (30) described 44
patients who underwent endovascular stent implantation
with important improvements in conduit longevity. How-
ever, Zeevi et al. (31) reported less positive outcomes, with
successful relief of obstruction in three of nine patients, one
of whom developed recurrence and required conduit re-
placement within 1 year after the procedure.
PTA valve replacement. Insufficiency of the truncal valve
before initial PTA repair has been associated with a higher
risk of early mortality (4,12,18,22) and poorer long-term
survival (3,18,19). Therefore, it is believed that replacement
or repair of a significantly regurgitant or stenotic truncal
valve at the time of PTA repair may be warranted
(4,12,18,19,21,22,32). Bove et al. (11) have asserted that the
truncal valve should be left alone at the time of PTA when
the degree of regurgitation is less than severe. Other series’
researchers have noted that preoperative truncal valve regur-
gitation was not significantly associated with increased early
mortality after PTA repair (3,17,18,20,21,24). Bove et al.
(21) and Marcelletti et al. (19) noted similar results on early
mortality, but assert that significant truncal valve regurgita-
tion complicates the operative and the early postoperative
course. Our study, similarly, did not show a significant
relation between hospital mortality after PTA repair and the
preoperative degree of truncal valve regurgitation.
As patients with important truncal valve dysfunction
often undergo truncal valve repair or replacement, contro-
versy exists as to whether the observed increased mortality at
PTA repair is associated with valve repair or replacement or
the presence of prerepair regurgitation. In our series, truncal
valve replacement at time of repair was performed for six
patients—three of whom had mild truncal valve regurgita-
tion (one hospital death, and one late death 9 months after
surgery), one moderate and two with severe regurgitation
(both died before hospital discharge). This represents a total
mortality rate of 67%. Brizard et al. (17) reported that
mortality related to replacement or repair of the truncal
valve at repair may explain the finding of truncal valve
regurgitation as a risk factor for hospital mortality. McEl-
hinney et al. (14) also report a high mortality after truncal
valve replacement. In their series of seven patients who had
replacement of their valve, 5 died early and 2 patients died
late after the operation. One of the late deaths occurred 8
months after initial truncal valve replacement and two
months after a second valve replacement was performed. All
but 1 of the 7 patients had severe truncal valve regurgitation
preoperatively. In our series, 5 truncal valve replacements
Figure 5. Kaplan-Meier estimates of freedom from initial conduit
replacement related to the type of conduit. Data relates to hospital
survivors after repair of persistent truncus arteriosus. Log rank p 5
0.002; Wilcoxon test p 5 0.008. PA 5 pulmonary artery; PTA 5
persistent truncus arteriosus; RV 5 right ventricle.
Figure 6. Kaplan-Meier estimates of freedom from initial conduit
replacement related to the influence of transcatheter balloon
dilation with or without endovascular stenting of conduit or
conduit valve stenosis. Data relates to hospital survivors following
repair of persistent truncus arteriosus. Dashed line represents
patients who did not have any intervening interventional cardiac
catheterization to address conduit obstruction (No cath); solid line
represents patients who had intervening interventional catheter-
ization (Cath); and broken line represents the same patients as the
solid line but under the assumption that if interventional cathe-
terization were not performed they would have had conduit
replacement at that date (If no cath). PA 5 pulmonary artery;
PTA 5 persistent truncus arteriosus; RV 5 right ventricle.
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were performed in 4 patients during follow-up procedures
after PTA repair, 2 of whom had mild and 2 of whom had
moderate regurgitation before repair. None of these patients
died. Unfortunately, the number is too small to draw
conclusions, but prerepair truncal valve regurgitation may be
a risk factor for need for late truncal valve replacement,
although this may be dependent on the degree of prerepair
regurgitation (17). Freedom from valve replacement is
better in those with mild regurgitation than in those with
moderate or severe regurgitation (14).
Conclusions. We conclude that there have been significant
trends toward improved mortality into the current era,
which have been marked by concomitant trends towards
improved early diagnosis and primary neonatal repair.
Nonetheless, important preoperative morbidity and mortal-
ity continue to occur. Hospital mortality after repair, al-
though improved, remains significant and ongoing morbid-
ity related to conduit obstruction and reoperation, and
truncal valve dysfunction and replacement or repair contin-
ues to dominate long term outcomes. There is growing
evidence to support the use of interventional cardiac cath-
eterization to address conduit and conduit valve obstruc-
tions and improve conduit longevity.
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